CHERAMI

Private Equity / Venture Capital Asset Managementifc-cherami.com

CHERAMI (谢诺投资) is a Guangzhou-based private equity and investment management firm offering equity, securities, overseas investment, and industry research services, primarily deploying over 10 billion RMB AUM into early-stage hard-technology companies in China.

Company typePrivate
Founded2013
HeadquartersGuangzhou, China
Headcount1–10
GTM typeB2B
OfferingServices

CHERAMI firmographics

Firmographics

Name: CHERAMI
Legal name: 广州谢诺投资集团有限公司
Website: https://ifc-cherami.com
Company type: Private
Founded year: 2013
Operating status: Operating
Headcount range: 1–10 employees
Short description: CHERAMI (谢诺投资) is a Guangzhou-based private equity and investment management firm offering equity, securities, overseas investment, and industry research services, primarily deploying over 10 billion RMB AUM into early-stage hard-technology companies in China.
Ownership category
akta.pro rank

CHERAMI industry classification

Industry

Product category: Private Equity / Venture Capital Asset Management
NAICS: All Other Financial Investment Activities (52399), Miscellaneous Financial Investment Activities (523999), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
SIC: Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)
akta.pro primary industry: Micro-PE / Lower Middle Market ETA Funds (FSANALAG)
akta.pro secondary industry: Family Office–Backed ETA (FSANALAH)

Keywords

Private equity investment
Venture capital management
Hard technology investment
Securities investment
Fund management services

Where CHERAMI is headquartered

Location

Headquarters

HQ city: Guangzhou
HQ country: China
HQ region: Asia

Offices4 records

Markets served

CHERAMI business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

CHERAMI product offering

Product offering

Core offering

CHERAMI is a private equity fund management firm that invests in and manages capital for early-stage hard-technology enterprises and listed companies. Its four business segments are Equity Investment (股权投资) in early-stage technology innovators, Securities Investment (证券投资) in listed equities within new energy, semiconductors, AI and biomedicine, an Industry Research Institute (产业研究院) producing frontier-technology research, and Overseas Investment (海外投资) supporting Chinese manufacturing enterprises expanding internationally, particularly into Africa.

Differentiator

Problem solved

Functional benefit

Brands

一心公益基金会: 公益基金会，致力于医疗卫生、救灾济困、扶贫助学、恤孤助残、环境保护等公益领域

Products and services

Equity Investment (股权投资) Early-stage equity investment service focused on hard-technology sectors, investing in technology-innovation companies with a multi-cycle, long-term capital approach.
Securities Investment (证券投资)

Quantifiable outcome

100+亿累计资产管理规模
+2 more outcomes

Companies that use CHERAMI

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles3 records

CHERAMI technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

CHERAMI partnerships and signals

Strategic signal

Scale indicators4 records

CHERAMI competitors and assessment

Company assessment

Direct peers

Sinovation Ventures (创新工场): China-focused tech investor spanning AI, robotics, biotech, and enterprise software. Comparable in early-to-growth hard-tech and AI mandate.
Fortune Capital (达晨财智): Shenzhen-based VC/PE firm investing across TMT, smart manufacturing, healthcare, and new energy in China. Directly comparable in domestic hard-tech focus and growth-stage equity strategy.
ZhenFund (真格基金): Prominent Chinese early-stage investor across deep tech, AI, biotech, and enterprise. Comparable in early-stage hard-tech concentration and Chinese limited-partner fundraising.
Eastern Bell Capital (东方富海): Shenzhen-based PE firm focused on hard-tech, advanced manufacturing, and healthcare in China. Comparable in domestic hard-tech equity focus and Chinese LP base.
Shenzhen Capital (深圳市创新投资集团): One of China's largest domestic VC/PE firms with broad hard-tech and growth-stage investing across China. Highly comparable in mandate (early-to-growth hard-tech) and Chinese institutional positioning.
Hongtai Capital (弘泰资本): China-focused growth equity investor across technology, healthcare, and consumer. Comparable in Chinese equity focus and growth-stage execution.
MatrixPartners China (经纬创投): Active early-stage investor in Chinese technology, healthcare, and consumer-internet sectors. Comparable in early-stage hard-tech mandate and Chinese institutional positioning.

Broad incumbents

IDG Capital: Long-tenured China-tech investor with broad sector coverage including semiconductors, AI, and healthcare. Comparable in long-duration tech investing but at meaningfully larger scale.
Hillhouse Capital (高瓴资本): Major China-focused investment platform across private equity, healthcare, and listed securities. Comparable in Chinese multi-strategy platform structure though at substantially larger AUM.
Sequoia Capital China (红杉中国): Largest and most established China-tech investor spanning seed to growth, AI, biotech, semiconductors. Comparable in hard-tech categories but operates at substantially greater scale and brand recognition.

Market position

Customer concentration

CHERAMI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CHERAMI leadership team

Management profile

Number of profiles

Profiles1 record

CHERAMI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CHERAMI M&A and investment

M&A and investment

M&A

Investments19 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CHERAMI

What does CHERAMI do?

Is CHERAMI a public or private company?

CHERAMI is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was CHERAMI founded?

CHERAMI was founded in 2013. It employs 1 to 10 people.

Where is CHERAMI based?

CHERAMI is headquartered in Guangzhou, China, in the Asia region.

Who are CHERAMI's main competitors?

Direct peers on record are Sinovation Ventures (创新工场), Fortune Capital (达晨财智), ZhenFund (真格基金), Eastern Bell Capital (东方富海), Shenzhen Capital (深圳市创新投资集团), Hongtai Capital (弘泰资本) and MatrixPartners China (经纬创投). Broad incumbents are IDG Capital, Hillhouse Capital (高瓴资本) and Sequoia Capital China (红杉中国).

Does CHERAMI have an API?

No public API is recorded for CHERAMI.

What industry is CHERAMI in?

CHERAMI's product category is Private Equity / Venture Capital Asset Management. Its primary akta.pro industry code is FSANALAG, Micro-PE / Lower Middle Market ETA Funds, with a secondary code of FSANALAH, Family Office–Backed ETA. Its NAICS code is 52399 and its SIC code is 6211.